Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 11, 2022

SELL
$12.69 - $19.25 $5,685 - $8,624
-448 Reduced 4.54%
9,425 $140,000
Q1 2022

Apr 19, 2022

BUY
$15.5 - $23.89 $24,412 - $37,626
1,575 Added 18.98%
9,873 $181,000
Q4 2021

Jan 28, 2022

BUY
$20.04 - $23.84 $166,291 - $197,824
8,298 New
8,298 $195,000

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.